Literature DB >> 6453154

H-2 restriction of adoptive immunotherapy of advanced tumors.

P D Greenberg, M A Cheever, A Fefer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6453154

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  16 in total

Review 1.  The next wave of recombinant and synthetic anticancer vaccines.

Authors:  K R Irvine; N P Restifo
Journal:  Semin Cancer Biol       Date:  1995-12       Impact factor: 15.707

Review 2.  Enhancing the recognition of tumour associated antigens.

Authors:  N P Restifo; B R Minev; A S Taggarse; B J McFarland; M Wang; K R Irvine
Journal:  Folia Biol (Praha)       Date:  1994       Impact factor: 0.906

Review 3.  Specific adoptive immunotherapy: experimental basis and future potential.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  Surv Immunol Res       Date:  1982

4.  Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients.

Authors:  W Den Otter; J W De Groot; H F Dullens
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response.

Authors:  N P Restifo; F Esquivel; A L Asher; H Stötter; R J Barth; J R Bennink; J J Mulé; J W Yewdell; S A Rosenberg
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

Review 6.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL.

Authors:  K R Irvine; B J McCabe; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

8.  Antigen processing in vivo and the elicitation of primary CTL responses.

Authors:  N P Restifo; I Bacík; K R Irvine; J W Yewdell; B J McCabe; R W Anderson; L C Eisenlohr; S A Rosenberg; J R Bennink
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

9.  Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

Authors:  K R Irvine; J B Rao; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

10.  Identification of human cancers deficient in antigen processing.

Authors:  N P Restifo; F Esquivel; Y Kawakami; J W Yewdell; J J Mulé; S A Rosenberg; J R Bennink
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.